Loading
Latest filing published 26 Aug 2024 for Agile Therapeutics INC, €1,325. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Sandra Carson in Agile Therapeutics Inc, where the filings describe the role as board member. In total, 5 filings cover trades dated from 9 June 2020 to 26 August 2024.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 26 August 2024: a transaction of €1,325, in Agile Therapeutics Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations